TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

21.311 Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5.
Avian influenza (H5N1) infections in humans. N Engl J Med 2005;353:1374-85.
21.312 Nichols WG et al. Respiratory viruses other than influenza virus: impact and therapeutic advances.
Clin Microbiol Rev 2008;21:274-90.
21.313 Falsey AR. Human metapneumovirus infection in adults. Pediatr Infect Dis J 2008;27(suppl.):S80-
3.
21.314 Kahn JS. Epidemiology of human metapneumovirus. Clin Microbiol Rev 2006;19:546-557.
21.315 Kahn JS. Newly identified respiratory viruses. Pediatr Infect Dis J 2007;26:745-6.
21.316 Crowe JE. Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr
Infect Dis J 2004;23(11 suppl.):S215-21.
21.317 Hamelin ME et al. Human metapneumovirus infection in adults with community acquired pneumonia
and exacerbation of chronic obstructive pulmonary disease. Clin Infect Dis 2005;41:498-502.
21.318 Williams JV et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy
infants and children. N Engl J Med 2004;350:443-50.
21.319 Semple MG et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial
virus is strongly associated with severe bronchiolitis. J Infect Dis 2005;191:382-6.
21.320 Meadows KP et al. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency
virus infected patients treated with cidofovir. Arch Dermatol 1997;133:987-90.
21.321 Sliva K et al. From actually toxic to highly specific-novel drugs against poxviruses. Virol J 2007;4:8.
21.322 Huhn GD et al. Clinical characteristics of human monkeypox and risk factors for severe disease. Clin
Infect Dis 2005;41:1742-51.
21.323 Di Giulio DB et al. Human monkeypox: an emerging zoonosis. Lancet Infect Dis 2004;4:15-25.
21.324 Fleischauer AT et al. Evaluation of human to human transmission of monkeypox from infected patients
to health care workers. Clin Infect Dis 2005;40:689.
21.325 Baker RO et al. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus
infections. Antiviral Res 2003;57:13-23.
21.326 Hviid A et al. Mumps. Lancet 2008;371:932-44.
21.327 Said MA et al. Gastrointestinal flu: norovirus in health care and long-term care facilities. Clin Infect
Dis 2008;47:1202-8.
21.328 Patel MM et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg
Infect Dis 2008;14:1224-31.
21.329 Anderson EJ. Prevention and treatment of viral diarrhea in pediatrics. Expert Rev Anti Infect Ther
2010;8:205-17.
21.330 Glass RI et al. Norovirus gastroenteritis. N Engl J Med 2009;361:1776-82.
21.331 Centers for disease Control and Prevention (CDC). Norwalk-like viruses. Public health consequences
and outbreak management. Morb Mortal Wkly Rep 2001;50(RR-9):1-17.
21.332 Dolin R. Noroviruses – challenges to control. N Engl J Med 2007;357:1072-3.
21.333 Lopman B et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new
norovirus variant. Lancet 2004;363:682-8.
21.334 Schiffman M et al. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
21.335 Gravitt PE et al. Diagnosis and management of oncogenic cervical human papillomavirus infection.
Infect Dis Clin North Am 2005;19:439-58.
21.336 Dunne EF et al. Genital human papillomavirus infection. Clin Infect Dis 2006;43:624-9.
21.337 Abdool Karim Q et al. Preventing HIV infection in women: a global health imperative. Clin Infect Dis
2010;50(suppl. 3):S122-9.
21.338 Riviera A et al. Therapy of cutaneous human papillomavirus infections. Dermatol Ther 2004;17:441-
8.
21.339 Harwood CA et al. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed
individuals. Br J Dermatol 2005;152:122-9.
21.340 Cha S et al. Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a
case report and review of the literature. Transpl Infect Dis 2005;7:158-61.
21.341 Bacelieri R et al. Cutaneous warts: an evidence based approach to therapy. Am Fam Physician
2005;72:647-52.
21.342 Gustafsson L et al. Treatment of skin papillomas with topical α-lactalbumin-oleic acid. N Engl J Med
2004;350:2663-72.
21.343 Zacharisen MC et al. Recurrent respiratory papillomatosis in children: masquerader of common respiratory
diseases. Pediatrics 2006;118:1925-31.
21.344 Bernard HU. Established and potential strategies against papillomavirus infections. J Antimicrob
Chemother 2004;53:137-9.
21.345 Partridge JM et al. Genital human papillomavirus infection in men. Lancet Infect Dis 2006;6:21-31.
21.346 Lacey CJ. Therapy for genital human papillomavirus related disease. J Clin Virol 2005;32(suppl. 1):
82-90.
21.347 Snoeck R et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir
�(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine�. J Med Virol 1998;54:219-25.
21.348 Snoeck R et al. Phase II double blind, placebo controlled study of the safety and efficacy of cidofovir
topical gel for the treatment of patients with human papillomavirus infection. Clin Infect Dis 2001;33:
597-602.
21.349 Horn TD et al. Intralesional immunotherapy of warts with mumps, Candida and Trichophyton skin test
antigens. A single blinded, randomized and controlled trial. Arch Dermatol 2005;141:589-94.
21.350 Beutner KR et al. Imiquimod, a patient applied immune response modifier for treatment of external
genital warts. Antimicrob Agents Chemother 1998;42:789-94.
21.351 Nichols WG et al. Respiratory viruses other than influenza virus: impact and therapeutic advances.
Clin Microbiol Rev 2008;21:274-90.
21.352 Wolthers KC et al. Human parechoviruses as an important viral cause of sepsislike illness and meningitis
in young children. Clin Infect Dis 2008;47:358-63.
21.353 Harvala H et al. Parechoviruses in children: understanding a new infection. Curr Opin Infect Dis
2010;23:224-30.
21.354 Pajkrt D et al. Clinical characteristics of human parechoviruses 4-6 infections in children. Pediatr Infect
Dis J 2009;28:1008-10.
21.355 Levorson RE et al. Human parechoviruses. Pediatr Infect Dis J 2009;28:831-2.
21.356 Young NS et al. Parvovirus B19. N Engl J Med 2004;350:586-97.
21.357 Douvoyiannis M et al. Neurologic manifestations associated with parvovirus B19 Infection. Clin Infect
Dis 2009;48:1713-23.